Disclosure Of Entity's Operating Segments [Text Block]

ERYTECH Pharma S.A. - Filing #858938

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of entity's operating segments [text block]	—	—	Information sectorielle	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)	—	—	521,000 EUR	—	—	2,000 EUR	—	3,000 EUR	—
Profit (loss)	—	228,000 EUR	228,000 EUR	—	53 797 EUR	53 797 EUR	—	73 300 EUR	73 300 EUR
Assets	45 811 EUR	—	—	66 768 EUR	—	—	80 402 EUR	—	—
Cash flows from (used in) operating activities	—	—	31 764 EUR	—	—	56 770 EUR	—	51 720 EUR	—
Cash flows from (used in) investing activities	—	—	38 127 EUR	—	—	345,000 EUR	—	1 475 EUR	—
Cash flows from (used in) financing activities	—	—	1 768 EUR	—	—	44 712 EUR	—	25 449 EUR	—